Epoetin Alfa Vials and Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
Determining the interaction of Epoetin Alfa Vials and Kisqali Femara Co-Pack 200 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: epoetin alfa
Brand name: Epogen, Procrit, Retacrit
Synonyms: Epoetin alfa, Epoetin Alfa
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Epoetin Alfa Vials-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Epoetin Alfa Vials-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Epoetin Alfa Vials-Kitabis Pak
- Epoetin Alfa Vials-Kitabis Pak inhalation
- Epoetin Alfa Vials-Klofensaid II
- Epoetin Alfa Vials-Klonopin
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Epoetin Alfa-epbx
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Epoetin alfa-epbx Injection
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Epoetin beta and methoxy polyethylene glycol
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Epogen
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Epoprostenol
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Epoprostenol Intravenous